Trial intelligence / Profile preview

Effectiveness of Concerta vs IR Methylphenidate in Children with ADHD

NCT00304681Phase 3Completed

Sponsor
Janssen Ortho
Modality
Small Molecules
01

Overview

A Phase 3 trial of methylphenidate-OROS in attention deficit hyperactivity disorder (ADHD), sponsored by Janssen Ortho. Status: completed.

02

Drugs

methylphenidate-OROS
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT00304681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00304681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call